company background image
500674 logo

Sanofi India BSE:500674 Stock Report

Last Price

₹6.84k

Market Cap

₹157.5b

7D

-28.5%

1Y

-1.3%

Updated

16 Jun, 2024

Data

Company Financials +

Sanofi India Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sanofi India
Historical stock prices
Current Share Price₹6,838.70
52 Week High₹10,526.05
52 Week Low₹5,850.55
Beta0.33
1 Month Change-22.79%
3 Month Change-12.45%
1 Year Change-1.34%
3 Year Change-10.36%
5 Year Change28.57%
Change since IPO1,853.91%

Recent News & Updates

Recent updates

Shareholder Returns

500674IN PharmaceuticalsIN Market
7D-28.5%1.7%2.7%
1Y-1.3%53.9%44.9%

Return vs Industry: 500674 underperformed the Indian Pharmaceuticals industry which returned 53.9% over the past year.

Return vs Market: 500674 underperformed the Indian Market which returned 44.9% over the past year.

Price Volatility

Is 500674's price volatile compared to industry and market?
500674 volatility
500674 Average Weekly Movement11.2%
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.5%
10% most volatile stocks in IN Market9.5%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 500674's share price has been volatile over the past 3 months.

Volatility Over Time: 500674's weekly volatility has increased from 6% to 11% over the past year.

About the Company

FoundedEmployeesCEOWebsite
19562,174Rodolfo Hroszwww.sanofiindialtd.com

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, central nervous system, anti-infectives, epilepsy, allergy and vitamins, and minerals and supplements, as well as pain care and nutritional health under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Glimepiride, Cetapin, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. It also exports its products to approximately 35 countries.

Sanofi India Limited Fundamentals Summary

How do Sanofi India's earnings and revenue compare to its market cap?
500674 fundamental statistics
Market cap₹157.50b
Earnings (TTM)₹5.49b
Revenue (TTM)₹28.47b

28.7x

P/E Ratio

5.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
500674 income statement (TTM)
Revenue₹28.47b
Cost of Revenue₹12.22b
Gross Profit₹16.25b
Other Expenses₹10.76b
Earnings₹5.49b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)238.42
Gross Margin57.06%
Net Profit Margin19.29%
Debt/Equity Ratio1.9%

How did 500674 perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

70%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.